Advisors Asset Management, Inc. Bio Rad Laboratories, Inc. Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$304.11 - $351.99 $2,432 - $2,815	8 Added 0.61%	1,316 $455,000
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $332,941 - $451,189	-1,236 Reduced 48.58%	1,308 $422,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $390,765 - $528,716	-1,087 Reduced 29.94%	2,544 $964,000
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $54,848 - $65,893	-131 Reduced 3.48%	3,631 $1.74 Million
Q3 2022 Nov 08, 2022	BUY	$412.59 - $563.26 $11,139 - $15,208	27 Added 0.75%	3,637 $1.52 Million
Q2 2022 Aug 08, 2022	BUY	$463.67 - $597.16 $565,213 - $727,938	1,219 Added 50.98%	3,610 $1.79 Million
Q1 2022 May 17, 2022	SELL	$524.57 - $735.42 $112,782 - $158,115	-215 Reduced 8.25%	2,391 $1.35 Million
Q4 2021 Feb 15, 2022	SELL	$708.84 - $794.68 $161,615 - $181,187	-228 Reduced 8.05%	2,606 $1.97 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $416,988 - $523,538	-634 Reduced 18.28%	2,834 $2.11 Million
Q2 2021 Jul 30, 2021	BUY	$576.64 - $649.04 $119,364 - $134,351	207 Added 6.35%	3,468 $2.23 Million
Q1 2021 May 07, 2021	SELL	$547.01 - $662.35 $1.17 Million - $1.41 Million	-2,131 Reduced 39.52%	3,261 $1.86 Million
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $113,370 - $142,845	-222 Reduced 3.95%	5,392 $3.14 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $47,260 - $55,702	-104 Reduced 1.82%	5,614 $2.89 Million
Q2 2020 Aug 12, 2020	SELL	$334.87 - $493.06 $102,470 - $150,876	-306 Reduced 5.08%	5,718 $2.58 Million
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $137,604 - $175,900	430 Added 7.69%	6,024 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $798,365 - $934,377	2,497 Added 80.63%	5,594 $2.07 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $264,958 - $300,358	870 Added 39.07%	3,097 $1.03 Million
Q2 2019 Aug 14, 2019	SELL	$286.93 - $312.59 $328,534 - $357,915	-1,145 Reduced 33.96%	2,227 $696,000
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $493,684 - $698,619	-2,201 Reduced 39.49%	3,372 $1.03 Million
Q4 2018 Jan 31, 2019	SELL	$220.1 - $309.0 $372,849 - $523,446	-1,694 Reduced 23.31%	5,573 $1.29 Million
Q3 2018 Nov 15, 2018	SELL	$289.28 - $326.15 $1.02 Million - $1.15 Million	-3,528 Reduced 32.68%	7,267 $2.27 Million
Q2 2018 Aug 22, 2018	SELL	$244.1 - $303.88 $12.9 Million - $16 Million	-52,781 Reduced 83.02%	10,795 $3.12 Million
Q2 2018 Aug 15, 2018	BUY	$244.1 - $303.88 $12 Million - $14.9 Million	49,037 Added 337.28%	63,576 $3.12 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $374,352 - $438,576	-1,600 Reduced 9.91%	14,539 $3.93 Million
Q4 2017 Feb 13, 2018	SELL	$216.94 - $271.3 $631,729 - $790,025	-2,912 Reduced 15.29%	16,139 $3.85 Million
Q3 2017 Nov 07, 2017	BUY	$212.27 - $242.28 $4.04 Million - $4.62 Million	19,051	19,051 $4.23 Million

Others Institutions Holding BIO

# of Institutions

461

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.24B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account